SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Aduro Clean Technologies, Inc. engages in the manufacture of oils and specialty chemicals using waste plastics. It focuses on hydrochemolytic technology to transform post-consumer polymer waste into a resource for the circular economy. It also develops a novel chemical conversion process to transform waste plastics and low grade renewable oils into renewable fuels and specialty chemicals. The company was founded on January 10, 2018 by Ofer Vicus and William Marcus Trygstad and is headquartered in Sarnia, Canada.

Aduro Clean Technologies Inc

The conversation is largely centered on the company's recent capital raises, including the closing of a LIFE offering, and ongoing advancements in its Hydrochemolytic technology, such as the new MOU with AstroTurf. While some investors express bullish sentiment based on the company's progress and potential for future commercialization, others remain skeptical, citing a long development timeline and questioning the economic viability of the company's core technology.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle shares are receiving attention after reporting a fiscal first-quarter "triple beat" on earnings and revenue, driven by triple-digit growth in cloud infrastructure and a record $664 billion backlog of AI cloud contracts. While the community expresses significant optimism over the company's AI-driven growth trajectory and cloud infrastructure expansion, some traders remain skeptical, citing concerns over negative free cash flow, substantial capital expenditure, and high debt levels.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as shareholders react to an insider purchase by CEO John Fieldly. While some investors interpret the CEO's open-market buy as a signal of confidence in a bottom, others remain skeptical, citing continued concerns over leadership performance and long-term brand growth.

Hunter Biden’s Laptop (LAPTOP) is a memecoin referencing the eponymous Hunter Biden laptop sensation that’s been a fixture in global media news cycles for the past six years. LAPTOP is a fungible, freely transferable, non-yield-bearing ERC-20 token on Base. As a memecoin, LAPTOP has no utility, but incorporates two novel distribution mechanics designed to promote long-term community growth: a large community airdrop and an event-based supply mechanism.

Hunter Biden's Laptop

The LAPTOP memecoin is facing intense criticism and a significant decline in value following its launch, with many in the community labeling the project a rug pull. Traders are heavily debating the risks of speculative meme coins and expressing widespread frustration over the token's immediate collapse from its initial price levels.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

The community is debating the potential for a market correction driven by a combination of surging oil prices, rising Treasury yields, and uncertainty ahead of key inflation data. While some traders suspect algorithmic manipulation and institutional support are propping up prices despite these headwinds, others are expressing bearish sentiment and anticipating a significant decline.

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

The S&P 500 is trending as traders react to persistent inflation concerns, including hot producer price index (PPI) data and a sharp rise in oil prices, which have increased the probability of a Federal Reserve rate hike. The community is sharply divided, with significant disagreement over whether economic indicators are being manipulated and high skepticism regarding government economic policies and stimulus promises.

Joby Aviation, Inc. is a transportation company, which engages in developing an all-electric, vertical take-off and landing aircraft that intends to operate as a commercial passenger aircraft. The company was founded by Bevirt Joebenn in 2009 and is headquartered in Santa Cruz, CA.

Joby Aviation Inc

Joby Aviation is trending as investors react to a positive Q2 earnings report that featured record revenue and raised full-year guidance, alongside announcements regarding the upcoming September launch of electric air taxi integration tests in Texas. While some traders are bullish on these operational milestones and the company's strong cash position, others remain focused on the impact of a planned $750 million at-the-market stock offering and the ongoing cash burn associated with scaling operations.

BioCryst Pharmaceuticals, Inc. is a biotechnology company. It engages in the provision of structure-guided drug design with the goal of developing oral small-molecule and protein therapeutics to target difficult-to-treat rare diseases. The company was founded by William M. Spencer III, Charles E. Bugg, and John A. Montgomery in 1986 and is headquartered in Durham, NC.

Biocryst Pharmaceuticals Inc.

BioCryst shares are experiencing downward pressure as investors react to a recent analyst downgrade that highlights concerns over increasing competition in the hereditary angioedema (HAE) market. The community is divided between frustration over the stock's prolonged range-bound performance and optimism that the current dip presents a buying opportunity given the company's established revenue base and potential pipeline catalysts.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Upstart shares are trending as traders express frustration over the company's inability to sustain gains following a strong earnings report. The community remains divided, with some pointing to macro-economic headwinds like interest rates and geopolitical risks as barriers to growth, while others highlight the company's upcoming bank charter and AI infrastructure potential as long-term bullish catalysts.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summit Therapeutics is trending due to significant insider buying, including $50 million in open-market purchases by co-CEOs, as traders watch for upcoming clinical data and the November PDUFA date for its lead oncology asset, ivonescimab. While some participants view the insider activity and recent trial updates as a strong bullish setup, others remain focused on the company's capital needs and the risks associated with regulatory uncertainty.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
